Development of a group A meningococcal conjugate vaccine,MenAfriVacTM

Baseline Meningococcal Carriage in Burkina Faso before the Introduction of a Meningococcal Serogroup A Conjugate Vaccine

(2011) Paul A. Kristiansen et al.   Clinical and Vaccine Immunology

Product Development Partnerships Hit Their Stride: Lessons From Developing A Meningitis Vaccine For Africa

(2011) David M. Bishai et al.   HEALTH AFFAIRS

Eliminating Epidemic Group A Meningococcal Meningitis In Africa Through A New Vaccine

(2011) F. Marc LaForce et al.   HEALTH AFFAIRS

Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans

(2011) Samba O. Sow et al.   NEW ENGLAND JOURNAL OF MEDICINE

The epidemiology of meningococcal disease in India

(2010) David Sinclair et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Determination of hydrazine in a meningococcal C conjugate vaccine intermediary product

(2010) Renata Chagas Bastos et al.   VACCINE

Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: A persistent problem with an imminent solution

(2009) F. Marc LaForce et al.   VACCINE

Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease

(2009) Carl E. Frasch et al.   VACCINE

Preparation of bacterial polysaccharide–protein conjugates: Analytical and manufacturing challenges

(2009) Carl E. Frasch   VACCINE

Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa

(2008) Che-Hung Lee et al.   VACCINE